Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
232.00    4.00 (1.75%)
Bid:
245.50
Ask:
232.00
Spread: -13.50 (-5.499%)
Market Cap: £630.23m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

CFO Appointment

15 Oct 2021 07:00

RNS Number : 1632P
Morgan Advanced Materials PLC
15 October 2021
 

Press Release

Morgan Advanced Materials plc

15 October 2021

 

CFO Appointment 

 

 

The Board of Morgan Advanced Materials plc is pleased to announce the appointment of Richard Armitage as Chief Financial Officer and Board director with effect from 30 May 2022.

 

Richard has a successful track record in financial leadership and brings strong commercial experience gained in a range of chemical and consumer goods businesses. He will join from Victrex plc (a FTSE 250 high-performance polymer solutions business) where he has held the CFO position since April 2018. Prior to Victrex, Richard was CFO at Samworth Brothers from 2014 to 2018, CFO of McBride plc from 2009 to 2014, and before that held senior finance positions at Courtaulds plc, ICI plc, and Premier Foods plc. Richard has been a non-executive Director of NWF plc since July 2020 and Chair of the Audit Committee at NWF plc since September 2020.

 

Richard will succeed Peter Turner, whose proposed retirement was announced on 6 May 2021. Peter will step down as CFO on 30 May 2022 and from the Board in June 2022 following a handover period.

 

Douglas Caster, Chairman, said:

"Following a comprehensive search, the Board is delighted to have selected Richard who shares our ambitions for the Group and will build upon the legacy left by Peter."

 

Pete Raby, CEO said:

"I look forward to working with Richard, who brings great experience and will be a strong addition to our team. He joins us at an important time as the impact of our strategy starts to show in our financial performance with faster growth and expanded margins and he will be instrumental in helping us to deliver."

 

There are no further disclosures to be made under Listing Rule 9.6.13 R.

 

For further enquiries:

Pete Raby Morgan Advanced Materials plc 01753 837 000

Nina Coad Brunswick 0207 404 5959

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFFEFULEFSEFS
Date   Source Headline
1st Jun 20264:35 pmRNSDirector/PDMR Shareholding
28th May 202610:10 amRNSHolding(s) in Company
26th May 20265:21 pmRNSDirector/PDMR Shareholding
18th May 20262:53 pmRNSHolding(s) in Company
13th May 20265:26 pmRNSHolding(s) in Company
12th May 20262:09 pmRNSDirector/PDMR Shareholding
7th May 20261:19 pmRNSResult of AGM
7th May 20267:00 amRNSCFO Intention to retire
7th May 20267:00 amRNSAGM Trading Update
29th Apr 20264:23 pmRNSDirector/PDMR Shareholding
9th Apr 20263:51 pmRNSHolding(s) in Company
31st Mar 20261:16 pmRNSDirector/PDMR Shareholding
26th Mar 20265:39 pmRNSDirector/PDMR Shareholding
26th Mar 20269:53 amRNSAnnual Financial Report
24th Mar 20262:44 pmRNSDirector/PDMR Shareholding
9th Mar 20269:34 amRNSDirector/PDMR Shareholding
5th Mar 20269:30 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSFull Year Results
23rd Feb 20269:00 amRNSHolding(s) in Company
2nd Feb 20264:12 pmRNSTotal Voting Rights
2nd Feb 20269:30 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSTransaction in Own Shares
9th Jan 20267:00 amRNSTransaction in Own Shares
8th Jan 20267:00 amRNSTransaction in Own Shares
7th Jan 20267:00 amRNSTransaction in Own Shares
6th Jan 20267:00 amRNSTransaction in Own Shares
5th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 202611:57 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
31st Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
30th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
29th Dec 20257:00 amRNSTransaction in Own Shares
24th Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
23rd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 202512:00 pmRNSBlock listing Interim Review
22nd Dec 20257:00 amRNSTransaction in Own Shares
22nd Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
19th Dec 20257:00 amRNSTransaction in Own Shares
18th Dec 20257:00 amRNSTransaction in Own Shares
17th Dec 20257:00 amRNSTransaction in Own Shares
16th Dec 20257:00 amRNSTransaction in Own Shares
15th Dec 20257:00 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.